SERPING1 and Sepsis: C1-INH administration in patients with sepsis was associated with reduced all-cause mortality (12 vs. 45% in the control, p = 0.008) and sepsis-related mortality (8 vs. 45% in the control, p = 0.001) assessed over 28 days.